LYST and neoplasm: It has been suggested that chemoresistance of CHS is caused by the phenotypic microenvironmental features of the tumor tissue, mainly chondrogenic ECM, and hypoxia, both possibly impeding the penetration of chemotherapeutic agents into the ECM and their diffusion to the tumor cells [14].